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Fibronectin Expression Determines Skin Cell Motile
Behavior
Kevin J. Hamill1,2, Susan B. Hopkinson1,2, Paul Hoover2, Viktor Todorovic´3, Kathleen J. Green2,3
and Jonathan C.R. Jones1,2
Mouse keratinocytes migrate significantly slower than their human counterparts in vitro on uncoated surfaces.
We tested the hypothesis that this is a consequence of differences in the extracellular matrix (ECM) that cells
deposit. In support of this, human keratinocyte motility was markedly reduced when plated onto the ECM of
mouse skin cells, whereas the latter cells migrated faster when plated onto human keratinocyte ECM. The ECM
of mouse and human keratinocytes contained similar levels of the a3 laminin subunit of laminin-332. However,
mouse skin cells expressed significantly more fibronectin (FN) than human cells. To assess whether FN is a
motility regulator, we used small interfering RNA (siRNA) to reduce the expression of FN in mouse
keratinocytes. The treated mouse keratinocytes moved significantly more rapidly than wild-type mouse skin
cells. Moreover, the FN-depleted mouse cell ECM supported increased migration of both mouse and human
keratinocytes. Furthermore, the motility of human keratinocytes was slowed when plated onto FN-coated
substrates or human keratinocyte ECM supplemented with FN in a dose-dependent manner. Consistent with
these findings, the ECM of a3 integrin-null keratinocytes, which also migrated faster than wild-type cells, was FN
deficient. Our results provide evidence that FN is a brake to skin cell migration supported by laminin-332-rich
matrices.
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INTRODUCTION
Skin cell migration is an essential aspect of epidermal wound
repair and carcinogenesis and is coupled with localized
compositional and organizational modification of the extra-
cellular matrix (ECM), as well as changes in expression and
activities of a variety of matrix receptors. In the skin, two major
ECM proteins, namely laminin a3b3g2 (LM332, formerly
laminin-5) and fibronectin (FN), are upregulated during
epithelial migration and both have been reported to support
cell motility (Clark et al., 1982; Nickoloff et al., 1988; Clark,
1990; Aumailley et al., 2005; Natarajan et al., 2006). However,
there are also published data indicating that LM332 and FN
inhibit migration of human keratinocytes (O’Keefe et al., 1985;
Kim et al., 1992; Morla et al., 1994; Zhang and Kramer, 1996;
O’Toole et al., 1997; Natarajan et al., 2006). These conflicting
data may reflect functional diversity of the matrix molecules
resulting from their posttranslational modification. Such is the
case with regard to LM332. Unprocessed LM332 functions to
support migration, whereas proteolytically cleaved LM332
stabilizes adhesion to the substrate by inducing hemidesmo-
some assembly (Goldfinger et al., 1998). Alternatively, matrix
components might either support or impede motility depending
on their microenvironment, including availability of cell
surface receptors and other binding partners. In this regard,
there is extensive evidence that matrix receptors are modulated
by cell and tissue context. For example, in keratinocytes, a6b4
integrin, a receptor for LM332, retards migration when
incorporated into hemidesmosomal adhesions, but activates
pathways that support cell migration in motile cells during
tumorigenesis and wound healing (Xia et al., 1996; Shaw et al.,
1997; Rabinovitz et al., 1999; Zahir et al., 2003; Pullar et al.,
2006; Sehgal et al., 2006). A similar situation may also exist for
a second LM332 receptor, namely a3b1 integrin, as there are
reports that it functions as both a positive and negative
regulator of keratinocyte migration (Hodivala-Dilke et al.,
1998; Reynolds et al., 2008; Margadant et al., 2009; Wen
et al., 2010).
Many advances in our understanding of how ECM
components and their receptors regulate skin cell motility
have been made in vitro using primary and immortalized
keratinocytes derived from normal and genetically
modified mice, as well as normal and diseased human skin
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(O’Keefe et al., 1985; Nickoloff et al., 1988; Marinkovich
et al., 1992; O’Toole et al., 1997; Hodivala-Dilke et al.,
1998; Nguyen et al., 2000a; Pullar et al., 2006; Sehgal et al.,
2006; Margadant et al., 2009). The considerable recent
improvements in the culture media of both mouse and human
keratinocytes prompted us to undertake a comparison of the
motility of primary and immortalized mouse and human skin
cells in some of these new media formulations. Surprisingly,
our results indicate that mouse keratinocytes move much
slower than their human counterparts when maintained in
commonly used, serum-free media. We investigated the
reason for this disparity and provide data indicating that the
motility of mouse keratinocytes is impeded by their deposi-
tion of FN into their matrix, a finding at odds with previous
results (O’Keefe et al., 1985; Nickoloff et al., 1988; Kim et al.,
1992). As part of our analyses, we also demonstrate that a3
integrin-null cells are deficient in FN deposition and discuss
this result in relation to the conflicting reports concerning
a3b1 integrin and its role in keratinocyte motility.
RESULTS AND DISCUSSION
We first analyzed the migration of passage 2 human foreskin
and passage 2 C57/Bl6 newborn mouse epidermal keratino-
cytes (primary human epidermal keratinocyte (pHEK) and
primary mouse epidermal keratinocyte (pMEK), respectively)
along with immortalized human and mouse epidermal
keratinocyte lines (iHEK and iMEK, respectively). For these
studies, all of our cells were maintained in serum-free
conditions and in low (0.07mM) calcium medium. We chose
passage 2 primary mouse cells for this study because primary
murine keratinocytes were difficult to maintain in culture
after more than three passages. Our migration assays
involved plating keratinocytes overnight onto uncoated
glass-bottomed dishes and then imaging cells every 2minutes
over 1 hour. Migration paths of individual cells were
tracked using Metamorph software and mean migration rates
were calculated (Figure 1a and b). These assays and time
courses were selected as they allow sufficient time for cells
to deposit and organize their own ECM before the start of
the study. Interestingly, pMEKs migrated significantly slower
than their human counterparts, whereas the migra-
tion rates of pHEKs were significantly slower than iHEKs
(total displacement rates: pMEK 0.68±0.09 mmmin–1, iMEK
0.57±0.01 mmmin–1, pHEK, 0.95±0.07 mmmin–1, iHEK
1.35±0.08 mmmin–1). There was no significant difference
in processivity (the ratio of net displacement to total
displacement) between pMEKs and pHEKs or between iMEKs
and iHEKs (Supplementary Figure S1a online). Intriguingly,
however, both primary lines displayed more intrinsic
processivity compared with their immortalized counterparts
(0.52±0.14 to 0.37±0.04 pMEK to iMEK, 0.50±0.09 to
0.31±0.06 pHEK to iHEK; Supplementary Figure S1a online).
Next, we sought to determine whether the slower
migration rates of the MEK lines were because of inherent
differences in the cytoplasmic motile machinery of mouse
versus human keratinocytes or because of differences in the
ECM these cells deposit. As a first test of this, we plated iHEKs
and iMEKs at near confluence overnight onto glass-bottomed
dishes and then used ammonium hydroxide treatment to
remove cellular material, leaving ECM material behind
(Gospodarowicz et al., 1980). We have previously shown
that this technique yields a substrate enriched in ECM
material and capable of supporting both cell attachment
and migration (Langhofer et al., 1993; Sehgal et al., 2006;
Todorovic et al., 2010a). iHEKs or iMEKs were plated onto
these prepared matrices, allowed to adhere and spread for
2 hours, and then their motile behavior was analyzed. This
shorter preassay attachment period was selected to minimize
the contribution of ECM deposition by the freshly plated cells
on their own motility. As expected, iMEKs on iMEK ECM and
iHEKs on iHEK ECM displayed motility rates that were not
significantly different from those when the same cells were
plated overnight onto uncoated glass (Figure 1c and d).
However, iHEKs plated on iMEK ECM migrated markedly
slower than iHEKs on iHEK ECM (0.88±0.25 vs.
1.33±0.29 mmmin–1, Figure 1c). Conversely, iMEKs plated
onto iHEK ECM exhibited a modest but significant increase in
their motility rates relative to iMEKs on iMEK ECM
(0.76±0.01 vs. 0.64±0.03 mmmin–1, Figure 1c). There were
no clear differences in processivity of human and mouse cells
regardless of the matrix used in these studies (Supplementary
Figure S1b online). Nevertheless, these data suggest that the
ECM deposited by iMEKs is an inferior substrate for
keratinocyte migration than the ECM of iHEKs.
To assess the possibility that these difference were related
to the ECM molecules that the cells deposit, we undertook
immunoblotting of cell lysates and ECM extracts of iMEKs
and iHEKs for two major keratinocyte ECM constituents, a3
laminin and FN (Clark et al., 1982; Nickoloff et al., 1988;
Clark, 1990; Aumailley et al., 2005). The matrices of iMEKs
and iHEKs contained FN and a3 laminin (Figure 2a).
However, there was more FN in the iMEK than in the iHEK
ECM. Immunofluorescence analyses using FN and LM 332
antibodies supported these observations (Figure 2b and c).
FACS analyses revealed that the relative deficiency of FN in
HEK matrix was not a result of a lack of surface expression of
the FN receptor a5b1 integrin by iHEKs (Figure 2d).
To assess whether the above findings were applicable to
other keratinocyte cell lines, we also assessed the motility
and FN expression of two additional immortalized human
(HaCaT and SCC25) and one immortalized mouse (PAM) skin
cell lines, all of which are maintained in serum-containing
media (Jones et al., 1982; Boukamp et al., 1988; Hu et al.,
1991). All three lines expressed FN at levels that greatly
exceeded that of iHEKs (Supplementary Figure S2a online).
They all stained positively for both FN and LM332, with the
latter being restricted within cell boundaries (Supplementary
Figure S2e and f online). This pattern was quite distinct from
that observed in iHEKs where LM332 antibody staining
reveals extensive tracks outside cell borders (Figure 2d). In
addition to this difference, the migration rates of the HaCaT,
SCC25, and PAM cells were significantly slower than iHEKs
(HaCaT 0.67±0.05, SCC25 0.60±0.03, PAM212
0.66±0.05 mmmin–1; Supplementary Figure S2b–d online).
Our analyses of the matrices deposited by MEK and HEK
raised the possibility that the differences in keratinocyte
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migration rates supported by iMEK and iHEK ECMs were
related to either differential proteolytic processing of a3
laminin or to the level of FN within each matrix. The former
possibility seemed unlikely as it has been reported that
matrices enriched in the unprocessed form of a3 laminin
supported migration, whereas matrices enriched in the
processed form supported stable adhesion of keratinocytes
(Goldfinger et al., 1998). iMEK ECM contained more 190 kD
unprocessed than 160 kD processed a3 laminin, and hence
might be expected to support more rapid cell motility
(Goldfinger et al., 1998). Although this result does not rule
out the fact that the differences in motility rates reflect
differential processing of the g2 or b3 subunits, we tested an
alternative hypothesis that FN in the matrix of the mouse
keratinocytes was the contributing factor to the lower
migration rates that iMEK matrix supported (Udayakumar
et al., 2003; Natarajan et al., 2006). To do so, we utilized
transient transfection of small interfering RNA (siRNA) against
the FN message to reduce FN expression in iMEKs (Figure 3a).
Transfected cells were plated onto glass-bottomed dishes and
motility behavior was analyzed. FN-knockdown iMEKs
exhibited significantly faster motility than control siRNA-
treated cells (0.86±0.14 vs. 0.57±0.1 mmmin–1, Figure 3b
and c). We also plated iMEKs and iHEKs onto the
ECM derived from FN-deficient iMEKs and assessed
their motility relative to iMEKs plated on control iMEK ECM
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Figure 1. Mouse epidermal keratinocytes (MEKs) migrate with lower velocities than human epidermal keratinocytes (HEKs). (a, b) Passage 2 primary MEKs
(pMEKs), immortalized MEKs (iMEKs), passage 2 primary HEKs (pHEKs), or immortalized HEKs (iHEKs) were plated overnight onto uncoated glass-bottomed
dishes and images were taken every 2minutes over 1 hour. Individual cells were tracked over the time course of the assay and the mean migration rates plotted.
(b) Representative vector diagrams depicting the migration tracks of 10 cells are shown. Each line represents the path over which a single cell has migrated
relative to its start position. (c, d) iMEKs or iHEKs were plated to reach 80–90% confluence on glass-bottomed dishes. After 24 hours, their extracellular matrices
(ECMs) were prepared. iMEKs or iHEKs were plated onto these ECMs, allowed to adhere for 2 hours, and then imaged every 2minutes over 1 hour. Individual
cells were tracked and their mean migration rates calculated. Representative vector diagrams of 10 cells are shown in d. Graphs in a and b represent meanþ SD
from a minimum of three assays per treatment with430 cells tracked per assay. *Significant differences between grouped populations, Po0.01. Axes of vector
diagrams¼ 50 mm.
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(Figure 3b). Results indicated that the matrix elaborated
by FN-deficient iMEKs supported more rapid migration
than the ECM of iMEKs for both iMEKs and iHEKs
(Figure 3b, iMEKs 0.79±0.15mmmin–1 on FNsiRNA ECM vs.
0.64±0.07mmmin–1 on iMEK ECM, iHEKs 1.21±0.25 on
FNsiRNA ECM vs. 0.83±0.18mmmin–1 on iMEK ECM).
Moreover, iMEK and iHEK migration rates on the FN-knock-
down ECM mirrored their motility rate when they were plated
onto the ECM derived from iHEKs (iMEKs 0.79±
0.15mmmin–1 on FNsiRNA ECM vs. 0.76±0.01mmmin–1 on
iHEK ECM, iHEK 1.21±0.25mmmin–1 on FNsiRNA ECM vs.
1.33±0.29mmmin–1 on iHEK ECM). No significant differences
in processivity were observed for mouse skin cells exhibiting
FN knockdown or for keratinocytes plated onto the FN-
depleted matrix deposited by mouse keratinocytes (Supple-
mentary Figure S1c online). These results were consistent with
a recent report in which plakoglobin-null MEKs were shown
to display 50-fold decreased FN expression compared with
expression of plakoglobin-expressing mouse skin cells and to
exhibit increased migration rates (Todorovic et al., 2010b).
To determine whether cell-mediated deposition and/or
organization of FN was required for its inhibitory effect, or
whether its presence was sufficient to slow migration, we
analyzed the motile behavior of iHEKs and FNsiRNA-treated
iMEKs plated onto dishes coated with soluble FN (Figure 3d
and e, Supplementary Figure S1d online). For both popula-
tions, significant reductions in motility rates were observed
when plated on FN versus their own matrix. We next sought
to determine whether addition of soluble FN to iHEK-derived,
laminin-332-rich matrix influenced the migration rate of
iHEKs plated upon it. iHEKs plated onto iHEK ECM
supplemented with FN migrated significantly slower than
those plated onto iHEK ECM lacking any supplement (Figure
3f and g and Supplementary Figure S1e online). Moreover,
the migration rate of HEKs on HEK matrix decreased with
increasing FN concentration (0.01 mgml–1 FN; 1.02±0.05,
0.1 mgml–1 FN; 1.00±0.09, 1 mgml–1 0.88±0.07, 10 mgml–1;
0.65±0.06 mmmin–1).
Cell migration rates have been demonstrated to possess a
biphasic relationship with adhesive strength, with intermedi-
ate ECM-coating concentrations providing optimal conditions
for rapid migration (DiMilla et al., 1993; Palecek et al., 1997;
Macdonald et al., 2008). These published observations
suggested the possibility that FN inhibited migration of
keratinocytes migrating on LM332 because of its ability to
enhance cell adhesion. To test this, we evaluated attachment
of iHEKs to uncoated surfaces or surfaces coated with
LM332-rich conditioned medium, with and without FN.
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Figure 2. Mouse epidermal keratinocytes (MEKs) deposit more fibronectin (FN) than human epidermal keratinocytes (HEKs). (a) Immortalized MEKs (iMEKs)
and immortalized HEKs (iHEKs) were plated onto uncoated tissue culture plastic dishes and, 24 hours later, cell lysates and extracellular matrix (ECM) extracts
were prepared for immunoblotting with antibodies against a3 laminin, FN, and lamin as indicated. (b, c) iMEKs and iHEKs were plated onto glass coverslips and,
24 hours later, were fixed and then imaged by confocal immunofluorescence microscopy following staining with antibodies against (b) FN or (c) LM332.
Phase-contrast images are shown in the lower panels. Bar¼10 mm. (d) FACS analyses of cell surface expression of a5b1 and a3 integrin expression were
determined for iHEKs, HaCaT, and SCC25 as indicated. In each plot, the filled trace represents the expression of the indicated antigen, whereas the hollow
trace represents nonspecific binding when secondary antibody is used alone.
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iHEKs attach more readily to FN-coated surfaces even in the
presence of LM332, suggesting that in our studies FN
inhibited migration, at least in part, by enhancing cell
adhesion to substrate (Figure 3h).
Intriguingly, our initial analyses of passage 2 human
primary keratinocytes revealed that although they migrated
significantly more rapidly than the equivalent passage of
primary mouse keratinocytes, their mean migration rate was
significantly slower than the iHEKs (Figure 1a). Previously, it
was demonstrated that FN expression decreased in fibro-
blastic cells with increasing passages and transformation
(Yamada et al., 1977). Increased passage number in human
keratinocytes has also been demonstrated to correspond to
increased migration rates (Sutherland et al., 2005). We
therefore assessed the FN expression and motility rates of
human primary keratinocytes with increasing passage num-
ber (p2–p3, 11–16 days after isolation; Figure 4a–c). Results
indicate that FN expression decreased markedly with
increasing passage, and that this decrease correlated with
an increase in migration rate (Figure 4a and b, p2,
0.58±0.03 mmmin–1 vs. p3, 0.81 mmmin–1). Moreover,
although the processivity of primary keratinocytes was
higher than the immortalized line, processivity decreased
with increasing passage number (Supplementary Figure S1f
online, iHEK 0.3±0.06, pHEK p2 0.5±0.09, pHEK p3
0.42±0.11).
We wondered whether differential expression of FN might
explain contradictory findings regarding the function of a
major keratinocyte ECM receptor a3b1 integrin in migration.
In brief, antibody blockade of a3b1 integrin inhibits migra-
tion of human keratinocytes on a LM332 substrate, whereas
mouse keratinocytes deficient in a3 integrin (iMEKa3–)
exhibit enhanced migration (Figure 5a and b; iMEKs
0.57±0.01 mmmin–1 vs. iMEKa3 0.73±0.09 mmmin–1; Gian-
nelli et al., 1997; Goldfinger et al., 1999; deHart et al., 2003;
Frank and Carter, 2004; Reynolds et al., 2008; Marga-
dant et al., 2009). Remarkably, we detected no FN in extracts
of iMEKa3– cells or their matrix (Figure 5c). More-
over, immunofluorescence analyses revealed a lack of
FN staining in iMEKa3– whereas LM332 was deposited in
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Figure 4. Migration rates of primary human epidermal keratinocytes (pHEKs) increase with increasing passage number. (a) pHEKs were isolated from multiple
neonatal foreskins and pooled to make a heterogeneous population. At each passage following isolation, a subset of cells was plated onto uncoated glass-bottomed
dishes. The next day, images were taken every 2minutes over 1hour and individual cells tracked. Mean migration ratesþ SD are plotted from three assays with430
cells per assay per passage. *Significance, Po0.01. (b) Representative vector diagrams depicting the migration paths of 10 cells are displayed. Axes¼ 50mm. (c) In
parallel with the motility assays, cell lysates were prepared from the cells at each passage for immunoblotting with antibodies against fibronectin (FN) and lamin.
Figure 3. Fibronectin (FN)-knockdown immortalized mouse epidermal keratinocytes (iMEKs) display increased migration rates. (a) iMEKs were transiently
transfected with either small interfering RNAs (siRNAs) targeting FN (FNkd) or scrambled siRNA (Scr). After 24 hours, transfected cells were plated onto uncoated
tissue culture dishes and allowed to elaborate matrix for 24 hours. Cell lysates and extracellular matrix (ECM) extracts were prepared for immunoblotting with
antibodies against FN and lamin as indicated. (b) iMEKs transfected with scrambled siRNA or siRNA against FN were plated onto uncoated glass-bottomed
dishes overnight and then images were taken every 2minutes over 1 hour. The migration of individual cells was tracked and their mean migration rates
determined (b, left 2 columns). In b, columns 3–6, iMEKs or FNsiRNA-transfected iMEKs were plated on glass-bottomed dishes. After 24 hours, their ECM was
prepared. Fresh iMEKs or immortalized human epidermal keratinocytes (iHEKs) were plated for 2 hours onto these ECMs, allowed to adhere for 2 hours, and then
imaged as above. (c) Representative vector diagrams of 10 cells viewed over the course of 1 hour are shown. (d) iHEKs, iMEKs, FNsiRNA-transfected iMEKs, and
iMEKa3– cells were plated for 2 hours onto FN-coated glass-bottomed dishes (coating was at 50 mgml–1) and their motility rates were determined with
representative vector diagrams being shown in e. (f, g) iHEK ECM was prepared and then incubated for 1 hour with either phosphate-buffered saline (PBS) alone
or with 0.01–10 mgml–1 FN in PBS. iHEKs were plated onto the prepared ECM and allowed to attach for 2 hours. In f, representative vector diagrams of 10 cells
viewed over the course of the subsequent 1 hour are shown, with motility rates being displayed in g. (h) Attachment of iHEKs to the indicated substrates was
evaluated at 30minutes and 1 hour after plating. Graphs in b, d, and g indicate mean migration ratesþ SD. Each plot is from a minimum of three assays per
treatment with 430 cells tracked per assay. *Significant differences between indicated populations, Po0.01. Axes of vector diagrams¼50 mm. Graph in h
represents mean absorbanceþ SD for assays performed in triplicate.
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extensive tracks (Figure 5d). The former result was not due to
a cell surface change in expression of the FN-binding integrin
a5b1 as FACS analyses revealed that the cell surface
expression levels of a5b1 integrin were similar in MEKs and
iMEKa3– (Figure 5e). Moreover, the motility of iMEKa3–
cells was inhibited on FN-coated surfaces, indicating that
their enhanced motility in vitro was likely due to their
inability to deposit FN into their matrix (Figure 5a and b,
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iMEKa3– on glass 073±0.09 mmmin–1 vs. iMEKa3– on FN
0.51±0.02 mmmin–1).
The data we present here raise some new questions about
the differences between cultured mouse and human kerati-
nocytes, the matrix they deposit, and the mechanisms of their
motility. Can one directly compare motility data from
cultured mouse and human keratinocytes or even mouse
cells of different genetic backgrounds? Our results argue that
to do so one must first perform analyses of the matrix they
deposit. In the absence of FN upon what are the iMEKa3–
cells migrating? Based upon our prior analyses of human
keratinocyte migration, we suggest that their motility is
supported by the LM332 they deposit (Goldfinger et al.,
1999). Why is FN deposition inhibited in pHEK and iHEK
cells in culture compared with pMEK and iMEKs? One
possible explanation is that there are differences in the way
FN expression is regulated at the transcriptional or transla-
tional levels in cultured human versus mouse keratinocytes
(Todorovic et al., 2010b). Alternatively, the apparent loss of
FN levels in the matrix of human skin cells may be due to
differences in activation and/or expression of cell surface
receptors involved in matrix protein expression, deposition,
and assembly. This would be consistent with the data we
present regarding FN deposition by iMEKa3– cells. Do our
results have relevance to skin wound repair in vivo? In a deep
wound, in which the basement membrane zone is compro-
mised, keratinocytes migrate over a provisional fibrinogen/
FN matrix covering the wound bed (Clark et al., 1982; Clark,
1990). It has long been assumed that this FN-rich matrix
supports migration of keratinocytes (O’Keefe et al., 1985;
Nickoloff et al., 1988). Our results argue that, in this context,
enhanced wound healing would be observed in areas where
keratinocytes are exposed to a matrix containing a reduced
rather than an increased FN content. In the wound environ-
ment, motile keratinocytes deposit a matrix enriched in
unprocessed LM332, demonstrated to support motility
(Marinkovich et al., 1992; Larjava et al., 1993; Zhang and
Kramer, 1996; Nguyen et al., 2000b). Thus, it is tempting to
speculate that keratinocyte motility during skin repair is, in
part, regulated by the balance between the negative and
positive effects of FN and LM332 present along the wound
bed. Analyses of wound healing in vivo will be required to
test such a possibility.
MATERIALS AND METHODS
Antibodies
Rabbit polyclonal antibodies against FN and a5b1 integrin were
purchased from Sigma Aldrich (St Louis, MO) and Abcam (Cambridge,
MA), respectively. Antibodies against lamin, a component of the
nuclear lamina, were obtained from Cell Signaling Technology
(Beverly, MA). Monoclonal antibody 10B5 against the a3 laminin
subunit and rabbit serum J18 against all three subunits of LM332 were
described previously (Langhofer et al., 1993; Goldfinger et al., 1998).
Mouse monoclonal antibodies against human a5b1 integrin (mAb
1969) and a3 (mAb 2056) were obtained fromMillipore (Billerica, MA).
Secondary antibodies conjugated with various fluorochromes
or horseradish peroxidase were purchased from Jackson Immuno-
Research Laboratories (West Grove, PA).
Tissue culture
Mice were maintained in accordance with local governmental and
institutional animal care regulations and all procedures had
institutional approval (Northwestern University IACUC protocol
number 2008-0215). Mouse keratinocytes were isolated from
newborn C57/Bl6 wild-type and a3 integrin-null mice (deHart
et al., 2003). Briefly, the skin of less than 1-day-old pups was
incubated in 5mgml–1 dispase solution (Sigma) overnight at 4 1C.
Following incubation, the dermal and epidermal layers were
separated using two pairs curved forceps and the epidermis
transferred and spread onto a 500ml drop of TrypLE Select
(Invitrogen, Carlsbad, CA). Following 30minutes of incubation at
room temperature, epidermal cells were dissociated by scraping,
then pelleted (160 g, 5minutes) and plated at 5 104 cells cm–2 in
Cnt07 complete media (CELLnTEC, Bern, Switzerland). Keratino-
cytes isolated as described above were immortalized through
infection with SV40 large T antigen (multiplicity of infection 0.5)
with media replaced every 3 to 4 days until keratinocytes cleared
senescence (Steinberg and Defendi, 1979).
Human primary keratinocytes were isolated from de-identified
human foreskins obtained from routine circumcisions performed on
neonates at Prentice women’s hospital (Chicago, IL; IRB project no.
STU00002257). Foreskins were washed extensively with phosphate-
buffered saline (PBS), cut into small pieces, and incubated overnight
on dispase (Sigma) at 4 1C. The following day, the dermis and
epidermis were separated using sterile forceps and the epidermis
incubated at 37 1C for 10minutes in 0.25% trypisn/1mM EDTA
solution. Following digestion, cells were dissociated from the tissue
through scraping, and filtered through a 40 mm sieve. Cells were
pelleted (220 g, 5minutes) and resuspended in M154 keratinocyte
growth media (Epilife, Cascade Biologics, Portland, OR), supple-
mented with 0.07mM CaCl2, human keratinocyte growth supple-
ment (including 0.18% hydrocortisone, 5mgml–1 transferrin, 0.2%
vol/vol bovine pituitary extract, 0.2 ngml–1 EGF, and 5mgml–1
insulin), gentamicin (10 mgml–1), and amphotericin B (0.25mgml–1;
Cascade Biologics). Human keratinocytes isolated as described
above were immortalized in the lab of Dr Lou Laimins at
Northwestern University using human papilloma virus E6 and E7
genes (Kaur et al., 1989). Immortalized HEKs were maintained in
defined keratinocyte serum-free medium (0.07mM CaCl2), and
supplemented with a proprietary growth factor mixture (serum
and bovine pituitary extract free; Invitrogen). HaCaT, 3T3 fibroblasts,
and PAM lines were maintained in DMEM (Invitrogen) supplemen-
ted with 10% fetal bovine serum (Hyclone, Logan UT). SCC25 were
maintained in DMEM/F12 mixture (Invitrogen) supplemented with
fetal bovine serum. All cell lines were maintained at 37 1C in a 5%
CO2 humidified environment.
For FN coatings, glass-bottomed dishes were incubated with
soluble FN (Sigma Aldrich, 50 mgml–1) in PBS for 1 hour. For siRNA
experiments, iMEKs were plated overnight at 1 105 cells per well in
six-well dishes. After 24 hours, cells were transfected to a final
concentration of 100 nM with either siRNA targeting FN (50-
AACAAATCTCCTGCCTGGGAC-30, Qiagen, Chatsworth, CA) or a
validated scrambled control siRNA (Qiagen) using Fugene 6
transfection reagent (Roche Applied Bioscience, Indianapolis, IN)
following the manufacturer’s recommendations. At 48 hours follow-
ing transfection, cells were trypsinized, pooled, and replated for
analysis.
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ECM preparations
Cell-derived ECM preparations were prepared as described pre-
viously (Langhofer et al., 1993). Briefly, cells were plated and
allowed to reach 80–90% confluency on tissue culture dishes or
glass-bottomed dishes. The culture medium was removed and the
cells were washed in sterile PBS. Cells were ruptured and cellular
material removed by treating them with sterile 20mM NH4OH
(Sigma Aldrich) for 5minutes, followed by three rapid washes in
sterile PBS. Keratinocytes were either plated directly onto the
prepared substrates or after 1 hour of incubation with either PBS or
0.01–10 mgml–1 FN in PBS as indicated.
Cell motility assays
Single-cell motility was measured as detailed by us previously
(Sehgal et al., 2006). Briefly, cells were plated onto 35-mm glass-
bottomed culture dishes (MatTek, Ashland, MA) and allowed to
adhere overnight onto uncoated dishes or for 2 hours onto dishes
coated with FN or cell-derived ECMs. The cells were then viewed on
a Nikon TE2000 inverted microscope (Nikon, Melville, NY). Images
were taken at 2-minute intervals over 1 hour, and cell motility
behavior was analyzed using a MetaMorph Imaging System
(Universal Imaging, Molecular Devices, Downingtown, PA). Statis-
tical analyses and significance were determined using the GraphPad
prism software (GraphPad Software, San Diego, CA).
Cell attachment assay
Individual wells of a 96-well plate (Sarstedt, Newton, NC) were
coated with 10mgml–1 FN in PBS (1 hour at 37 1C), LM332-
conditioned media (2 hours at 37 1C), or LM332-conditioned media
followed by 10mgml–1 FN. Wells were then blocked in 5% BSA for
1 hour before plating of 1 105 iHEKs per well. After 30 or
60minutes at 37 1C, the cells were washed extensively with PBS to
remove nonattached cells. Adherent cells were then fixed in 3.7%
formaldehyde in PBS for 15minutes at room temperature. The fixed
cells were incubated at room temperature with 0.5% crystal violet for
15minutes and then solubilized with 1% SDS. A570 was measured
with a Vmax plate reader (Molecular Devices, Menlo Park, CA).
Immunofluorescence microscopy, SDS-PAGE, and western
immunoblotting
Cultured cells on glass coverslips were processed as detailed
previously (Sehgal et al., 2006). All preparations were viewed with
a confocal laser-scanning microscope (UV LSM 510, Zeiss, Thorn-
wood, NY). Images were exported as TIFF files, and figures were
prepared using Adobe Photoshop and Illustrator software.
Total cell lysates and matrix extracts of cells 2 days after plating
were prepared as described previously using a sample buffer
comprising 8 M urea, 1% SDS, and 10mM Tris-HCl, pH 6.8 (Riddelle
et al., 1991; Langhofer et al., 1993). Protein samples were processed
for SDS-PAGE and immunoblotting as detailed elsewhere (Harlow
and Lane, 1988; Riddelle et al., 1991). To control for loading, whole
cell lysates and ECMs were prepared from replica plates seeded with
identical numbers of cells (1.5 106 cells per 100mm dish). Lamin
reactivity on western blots was used to confirm equal loading of
whole-cell lysates. To control for loading of the ECMs, isolated
matrix was solubilized in half the volume of sample buffer used to
solubilize whole-cell lysates. Equal volumes of cell lysates and ECMs
were loaded onto each gel.
FACS
For flow cytometry, freshly trypsinized cells were resuspended in
PBS containing a 50% dilution of normal goat serum, incubated with
monoclonal antibodies against a5b1 integrin or a3b1 integrin for
45minutes at room temperature, washed with PBS, incubated with
FITC-conjugated goat anti- mouse IgG for 45minutes, washed,
resuspended in PBS, and analyzed using a Beckman Coulter Elite
PCS sorter (Beckman Coulter, Fullerton, CA). For negative controls,
primary antibody was omitted from the above procedure.
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